Keith Pagnani

Practice Areas

Mergers & Acquisitions; Corporate Governance; Healthcare & Life Sciences; M&A Financial Advisory; Financial Services; Intellectual Property & Technology Transactions; Private Equity

Career

Keith Pagnani is a partner in S&C’s Mergers & Acquisitions Group and co-head of the Firm’s Healthcare and Life Sciences Group. He is actively involved in S&C’s corporate practice and has broad experience in domestic and cross-border M&A transactions. He is a recognized leader in the healthcare and pharmaceuticals industry, and has been recognized as The American Lawyer’s “Dealmaker of the Week” for advising UnitedHealth in OptumRx’s combination with Catamaran and “Dealmaker of the Year” for advising Alcon’s independent directors committee in Alcon’s acquisition by Novartis.

Recent representations include: Booking Holdings in its $1.2 billion acquisition of Getaroom; Harris’s $35 billion merger of equals with L3 Technologies and L3Harris’ approximately $1.96 billion acquisition of Viasat’s Tactical Data Links product line and $1.05 billion sale of its Military Training business to CAE; Praxair’s $80 billion merger of equals with Linde; Special Committee of the Board of Directors of Teck Resources in the potential spin-off of Teck’s steelmaking coal business; UnitedHealth in connection with Optum’s $6 billion merger with LHC Group, $13.8 billion acquisition of Change Healthcare and $4.3 billion acquisition of DaVita Medical; and Delta’s agreement with Air France-KLM to acquire a 10% stake in Air France.

Keith is a member of Tulane University Law School’s Corporate Law Institute Planning Committee and regularly moderates and speaks on panels related to M&A, governance, healthcare and other corporate matters.

Professional Memberships

Member, Tulane University Law School’s Corporate Law Institute Planning Committee.

Personal

Catholic University of America Columbus School of Law (JD, 1989); Dickinson College (BA, 1986).